ライフサイエンスコーパス: task force

1 verweight, or obesity (International Obesity Task Force).

2 adults to inform the US Preventive Services Task Force.

3 of CVD to inform the US Preventive Services Task Force.

4 escents to inform the US Preventive Services Task Force.

5 and Prevention Community Preventive Services Task Force.

6 al Association, and U.S. Preventive Services Task Force.

7 as recommended by the International Obesity Task Force.

8 patients is recommended by an international task force.

9 auma have been developed by a multispecialty task force.

10 sk assessment for the US Preventive Services Task Force.

11 ars and older for the US Preventive Services Task Force.

12 of OSA, to inform the US Preventive Services Task Force.

13 factors to inform the US Preventive Services Task Force.

14 5 years to inform the US Preventive Services Task Force.

15 ociety of Intensive Care Medicine convened a task force (19 participants) to revise current sepsis/se

16 ollege of Allergy, Asthma & Immunology Joint Task Force 2012 AD Practice Parameter and the 2014 Ameri

17 The Task Force achieved a comprehensive position in defining

18 y 69% to achieve the Gulf of Mexico Nutrient Task Force Action Plan target hypoxic area of 5000 km(2)

19 It recommends that the Task Force adopt a balanced approach to evaluating the b

20 f Physicians (ACP), U.S. Preventive Services Task Force, American Academy of Family Physicians, Ameri

21 llergy and Clinical Immunology have formed a task force and developed a drug allergy passport as well

22 rican College of Physicians' High Value Care Task Force and the Centers for Disease Control and Preve

23 flicts of interest, all members of the Joint Task Force and the Practice Parameters Workgroups will c

24 ndations were approved by all members of the task force and then assembled into a complete document.

25 itation and Chronic Care Group established a Task Force and writing committee to develop a policy sta

26 atistical Manual of Mental Disorders (DSM-5) Task Force announced that the planned introduction of AP

27 A multidisciplinary task force at a pediatric hospital developed an evidence

28 The Task Force based the recommendation primarily on the res

29 espite these limitations, the members of the Task Force believe that these recommendations provide a

30 y taking a broader view of the evidence, the Task Force can write new guidelines that will serve effo

31 onths according to the International Obesity Task Force classification.

32 This process resulted in the final ISBD Task Force clinical recommendations on antidepressant us

33 The Task Force commissioned an evidence review that assessed

34 In September 2013, a multidisciplinary task force, composed of pediatric practitioners from ter

35 Delphi process; (2) a Delphi study among the task force comprising 3 surveys and discussions of resul

36 The Task Force concluded that postmenopausal women with an e

37 The task force concluded that requesting competency-based tr

38 The task force concluded the term severe sepsis was redundan

39 cent reports from the US Preventive Services Task Force concluding that there was insufficient eviden

40 and management guidelines are based on that task force consensus and should continue to evolve as cl

41 The 18-member task force consisted of experts including pulmonologists

42 consensus document was prepared by an EAACI Task Force consisting of an expert panel of allergologis

43 s consensus document was prepared by a EAACI Task Force consisting of an expert panel of allergologis

44 A project task force, consisting of the committee as a whole, was

45 Because of limited data, the task force could not make broad statements endorsing ant

46 t, Development, and Evaluation expert on the Task Force created profiles for the evidence related to

47 e development of a new criterion by the 2010 Task Force Criteria (not the "Hamid criteria") at last f

48 is (n=31) were older (P=0.005) and met fewer Task Force Criteria (P=0.013) than those who developed H

49 esonance (CMR) is a component of the revised Task Force Criteria (rTFC) for the diagnosis of arrhythm

50 med to determine cardiac MR imaging-specific Task Force Criteria (TFC) and non-TFC features (ARVD/C-t

51 diagnostic criteria for ARVD/C (2010 Revised Task Force Criteria [TFC]) was studied.

52 tients who fulfilled the 2010 ARVC/D Revised Task Force Criteria and underwent baseline transthoracic

53 gnostic value of fat quantification by using task force criteria as a reference.

54 We examined 62 consecutive patients with Task Force criteria for arrhythmogenic right ventricular

55 Although the Task Force Criteria for arrhythmogenic right ventricular

56 bers with mutations were more likely to meet Task Force Criteria for ARVD/C (40% versus 18%), experie

57 The Movement Disorder Society Task Force criteria were used to classify the Parkinson'

58 LV involvement related to none of the Task Force criteria.

59 adjudicated for 289 patients meeting ARVC/D Task Force Criteria.

60 ed an ARVD/C diagnosis according to the 2010 Task Force Criteria.

61 ucture and function according to the revised task force criteria.

62 zed for electrical abnormalities per revised task force criteria.

63 based on the presence of 2010 International Task Force criteria: 1) subclinical stage (n = 21); 2) e

64 he Third International Consensus Definitions Task Force defined sepsis as "life-threatening organ dys

65 This document summarizes the task force deliberations and follow-up discussions, and

66 oderate) DED patients based on International Task Force Delphi Panel severity grading, and controls,

67 In 2004, the U.S. Preventive Services Task Force determined that evidence was insufficient to

68 In 2004, the U.S. Preventive Services Task Force determined that evidence was insufficient to

69 The task force determined the in vivo allergenic potency (10

70 The Task Force developed 10 weak recommendations.

71 The Task Force developed a single strong recommendation: we

72 ient but expert consensus was unanimous, the Task Force developed six good practice statements.

73 this paper reviews the process by which the task force developed the new evidence-based guideline, t

74 s of 85 patients with ARVD/C fulfilling 2010 Task Force diagnostic criteria (TFC) from a transatlanti

75 The task force, divided into four subcommittees, collaborate

76 ade because of the scarcity of evidence, the task force either used evidence from studies of patients

77 The task force encompassing the authors of this article prov

78 Preventive Services Task Force endorsed aspirin for primary prevention of ca

79 f expert committees-U.S. Preventive Services Task Force) evidence.

80 The 'Allergy and Asthma Severity' EAACI Task Force examined the current evidence and produced th

81 This white paper summarizes the task force findings and makes recommendations for future

82 This paper is the compilation of a task force focussed on practical aspects of this techniq

83 scents to support the US Preventive Services Task Force for an updated recommendation statement.

84 defects to inform the US Preventive Services Task Force for an updated Recommendation Statement.

85 In the present study, the task force for house dust mite (HDM) allergen standardiz

86 g from the United States Preventive Services Task Force for population-based skin cancer screening.

87 At IWWM-8, a task force for treatment recommendations was impanelled

88 eutics (ASRS ReST) Committee, an independent task force formed to monitor device-related and drug-rel

89 Here, the task force further clarifies and expands 3 topics discus

90 are epitomized by the US Preventive Services Task Force giving prostate specific antigen-based prosta

91 iology Foundation/American Heart Association Task Force Guideline for the Diagnosis and Treatment of

92 Approaches to therapy for GID and task force guidelines are noted.

93 ervals recommended by the 2008 Multi-Society Task Force guidelines.

94 The Task Force has asked modelers to reassess the loading re

95 A task force has developed tools to facilitate and rapidly

96 The US Multi-Society Task Force has developed updated recommendations to guid

97 Although the task force has the final responsibility for the content

98 Although the Task Force has the final responsibility for the content

99 and Prevention and U.S. Preventive Services Task Force have highlighted public screening as an essen

100 ege of Cardiology/American Heart Association Task Force have published new guidelines on the manageme

101 ng the recommendations of the Organ Donation Task Force in 2008 has had a major impact in bringing to

102 ntions to support the US Preventive Services Task Force in updating its 2008 recommendation.

103 rning paradigms; and 3) the establishment of task forces in emerging areas of multimodality imaging a

104 The Multi-Society Task Force, in collaboration with invited experts, devel

105 The task force included recommendation statements in the fin

106 For this task force initiative of the European Academy of Allergy

107 Therefore, this Task Force initiative of the European Academy of Allergy

108 To address this unmet need, an international task force involving experts from different organization

109 The Joint Task Force is committed to ensuring that the practice pa

110 The consensus of the task force is that older men with prostate cancer should

111 ual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI o

112 ual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI o

113 ual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI o

114 son, including those who served on the Joint Task Force, is authorized to provide an official AAAAI o

115 November 2013, the U.S. Preventive Services Task Force issued a guideline on medications for risk re

116 In May 2015, the U.S. Preventive Services Task Force issued a guideline on screening for thyroid d

117 f aspirin in primary disease prevention, the Task Force issued a guideline titled, "Aspirin Use for t

118 An expert task force iteratively developed consensus through seria

119 classified using Movement Disorders Society Task Force level I (Montreal Cognitive Assessment <26) a

120 cal or optimal clinical practice varies, the Task Force made no recommendations for nine of the topic

121 The task force makes 10 CRC screening recommendations that e

122 uthor's name in the AJCC Ophthalmic Oncology Task Force Member Authors section in the Article Informa

123 rnational Liaison Committee on Resuscitation task force members are provided in Values and Preference

124 Task force members conducted additional independent sear

125 Finally, the task force members have prioritized and listed the top 3

126 Task force members narrowed the list to the Top 5 items

127 Task Force members reviewed this material and all availa

128 Delphi method, with anonymous voting by all task force members using E-Survey.

129 All task force members were allowed to review the literature

130 Task force members were charged with comprehensively cat

131 tential conflict of interest was followed if task force members were coauthors of related research.

132 ating the evidence and the experience of the task force members, a consensus was reached on 12 statem

133 EDLINE search and references provided by all task force members.

134 equired the agreement of at least 80% of the task force members.

135 ups met via conference calls, and the entire task force met in person for a 2-day session.

136 y, both in person and by teleconference, the task force met to construct these recommendations.

137 A task force (n = 19) with expertise in sepsis pathobiolog

138 y in the middle of the International Obesity Task Force normal weight range, but during adulthood, th

139 4; 95% CI, 1.15-6.06), International Obesity Task Force obesity cutoffs (OR, 2.38; 95% CI, 1.06-5.34)

140 A multispecialty task force of 16 international experts in critical care

141 ng recommendations of the U.S. Multi-Society Task Force of Colorectal Cancer (MSTF), which represents

142 A multi-specialty task force of international experts in critical care med

143 A task force of surgeons and professional educators develo

144 The Amyloid Imaging Task Force of the Alzheimer's Association and Society fo

145 This systematic review was requested by the Task Force of the American Academy of Periodontology as

146 The male health task force of the COG-LTFU Guidelines, composed of pedia

147 The current survey, which was conducted by a task force of the European Academy of Allergy and Clinic

148 The multidisciplinary palliative care task force of the European Association of Neuro-Oncology

149 The meningioma task force of the European Association of Neuro-Oncology

150 A Task Force of the Immunotherapy and Aerobiology and Poll

151 cy cardiovascular care follows the Pediatric Task Force of the International Liaison Committee on Res

152 EAACI Task Force on 'Contraindications to AIT' was created to

153 ean Academy of Allergy & Clinical Immunology Task Force on Anti-infectives in Asthma was initiated to

154 The Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR) in 2015

155 In a previous publication, the Transatlantic Task Force on Antimicrobial Resistance (TATFAR) summariz

156 onal guidelines created by the 2012 European Task Force on Atopic Dermatitis and the 2013 Asia-Pacifi

157 The US Multi-Society Task Force on Colorectal Cancer, with invited experts, d

158 ing the US Institute of Medicine, the Global Task Force on Expanded Access to Cancer Care and Control

159 e American College of Critical Care Medicine Task Force on Models of Critical Care: 1) An intensivist

160 n Academy of Allergy and Clinical Immunology Task Force on NSAIDs Hypersensitivity, aims at reviewing

161 ology (ACC)/American Heart Association (AHA) Task Force on Practice Guidelines recently issued the 20

162 idelines from the American Heart Association Task Force on Practice Guidelines.

163 idelines from the American Heart Association Task Force on Practice Guidelines.

164 These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP), representing

165 These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP), representing

166 ompared with those created by the 2012 Joint Task Force on Practice Parameters representing the Ameri

167 The Joint Task Force on Practice Parameters understands that the c

168 This parameter was developed by the Joint Task Force on Practice Parameters, representing the Amer

169 This parameter was developed by the Joint Task Force on Practice Parameters, representing the Amer

170 This parameter was developed by the Joint Task Force on Practice Parameters, representing the Amer

171 Description: The Joint Task Force on Practice Parameters, which comprises repre

172 A European Respiratory Society Task Force on Pulmonary-Hepatic Disorders convened in 20

173 matic review by the U.S. Preventive Services Task Force on screening and supplementation for IDA in p

174 date evidence for the US Preventive Services Task Force on the benefits and harms of hormone therapy

175 DeCaprio A, Carpenter DO, and the Akwesasne Task Force on the Environment.

176 nt conclusions of the US Preventive Services Task Force on the need for further data that address exi

177 C) and the United States Preventive Services Task Force on whom to screen for HIV and HCV infections,

178 sk of obesity based on International Obesity Task Force or World Health Organization body mass index

179 In this task force paper of the Interest Group on Biologicals of

180 ittee on Resuscitation Advanced Life Support Task Force performed a systematic review to evaluate 3 k

181 In this EAACI task force position paper, we provide an overview of the

182 itial list of 58 unique recommendations, the task force proposed a Top 5 list that was ultimately end

183 n October 2015, the U.S. Preventive Services Task Force published recommendations on screening for ab

184 y quality using the U.S. Preventive Services Task Force quality rating criteria.

185 Collaboratively and iteratively, the task force reached consensus using a roundtable meeting,

186 The U.S. Preventive Services Task Force recently concluded that the harms of existing

187 An intergovernmental Task Force recently extended to 2035 the deadline for ac

188 The US Preventive Services Task Force recently recommended the use of aspirin to pr

189 An international task force recently redefined the concept of sepsis.

190 ol and Prevention and US Preventive Services Task Force recommend one-time hepatitis C virus (HCV) te

191 Community Preventive Services Task Force recommendation on the use of combined diet an

192 a radiologist discuss the application of the Task Force recommendation to an individual patient.

193 holesterol and 2016 U.S. Preventive Services Task Force recommendations for statin use in primary pre

194 This review summarizes the current task force recommendations for the assessment and manage

195 This review summarizes current task force recommendations for the assessment and manage

196 guidelines and 2016 U.S. Preventive Services Task Force recommendations, respectively.

197 More recently, the U.S. Preventive Services Task Force recommended "initiating low-dose aspirin use

198 ations: Recently, the US Preventive Services Task Force recommended any of 8 CRC screening approaches

199 Preventive Services Task Force recommended biennial mammography screening fo

200 December 2013, the U.S. Preventive Services Task Force recommended screening for lung cancer with lo

201 organisations and the US Preventive Services Task Force recommended that screening should be implemen

202 This task force recommended the use of the quick Sequential O

203 The task force recommends against prehospital cooling with r

204 Preventive Services Task Force recommends against routine screening for colo

205 The Task Force recommends glucose screening every 3 years fo

206 The United States Preventive Services Task Force recommends lung cancer screening with low-dos

207 The task force recommends targeted temperature management fo

208 eening instrument and simple assessment, the task force recommends that patients are classed into thr

209 The Task Force recommends the use of combined diet and physi

210 To update the 2008 U.S. Preventive Services Task Force review on dyslipidemia screening in younger a

211 Preventive Services Task Force review on the benefits and harms of screening

212 dback on the draft document, which the Joint Task Force reviewed before finalizing the guideline.

213 The parameter was then evaluated by Joint Task Force reviewers and then by reviewers assigned by t

214 rkgroup convened to draft the parameter, the task force reviewers, and peer review by members of each

215 rkgroup convened to draft the parameter, the Task Force Reviewers, and peer review by members of each

216 isk [RR], 0.80 [95% CI, 0.73-0.89]; Canadian Task Force: RR, 0.82 [95% CI, 0.74-0.94]; Cochrane: RR,

217 iplinary discussion, a COG Return of Results Task Force (RRTF) offered detailed recommendations for t

218 average) set by the national Gulf of Mexico Task Force's Action Plan.

219 This article examines the Task Force's process for writing its guidelines.

220 sed on the United States Preventive Services Task Force scheme.

221 igo Area Scoring Index and Vitiligo European Task Force scoring system.

222 he Third International Consensus Definitions Task Force (Sepsis-3) recently recommended changes to th

223 ciplinary field of AllergoOncology was given Task Force status by the European Academy of Allergy and

224 A task force supported by the American Thoracic Society, C

225 As elaborated by a Task Force (TF) of the European Academy of Allergy and C

226 In conjunction with the Joint Task Force, the workgroup reviewed the evidence and deve

227 According to the US Preventive Services Task Force, there is no sufficient evidence to recommend

228 tic Association convened a multidisciplinary task force to address cardiovascular concerns in collegi

229 Critical Care Medicine has also assembled a task force to assess the long-term consequences of criti

230 of Retina Specialists (ASRS) formed a joint task force to define clinical characteristics of HORV an

231 e CF Foundation convened a multi-stakeholder task force to develop CRC screening recommendations.

232 een validated in adults; and (5) establish a task force to engage third-party payers in discussions o

233 f Neuro-Oncology created a multidisciplinary task force to establish evidence-based guidelines for im

234 managing patients with MSI; Pain Management Task Force to optimize care for wounded soldiers; Muscul

235 ergy and Clinical Immunology has organized a task force to provide data and recommendations regarding

236 ical Care Societies Collaborative convened a task force to review these CCM pathways and to provide r

237 Critical Care Medicine assembled a 20-member task force to revise the 2002 guidelines for sedation an

238 iety for Bipolar Disorders (ISBD) convened a task force to seek consensus recommendations on the use

239 RATIONALE: The Sepsis-3 Task Force updated the clinical criteria for sepsis, exc

240 The task force used Grading of Recommendations Assessment, D

241 relative accuracy of US Preventive Services Task Force (USPSTF) and American College of Cardiology/A

242 In November 2009, the US Preventive Services Task Force (USPSTF) changed its mammography recommendati

243 efficiency with the U.S. Preventive Services Task Force (USPSTF) criteria for identifying screenees,

244 The U.S. Preventive Services Task Force (USPSTF) develops evidence-based recommendati

245 In 2012, the US Preventive Services Task Force (USPSTF) discouraged prostate-specific antige

246 ommendations from the US Preventive Services Task Force (USPSTF) emphasize therapy based on the prese

247 0 to 69 years), and U.S. Preventive Services Task Force (USPSTF) guidelines (biennial for those aged

248 Preventive Services Task Force (USPSTF) guidelines for breast cancer mammogr

249 The US Preventive Services Task Force (USPSTF) is updating its 2008 colorectal canc

250 The U.S. Preventive Services Task Force (USPSTF) makes recommendations for 60 distinc

251 The U.S. Preventive Services Task Force (USPSTF) makes recommendations on which preve

252 The US Preventive Services Task Force (USPSTF) makes recommendations to primary car

253 In July 2014, the U.S. Preventive Services Task Force (USPSTF) published a clinical guideline on sc

254 The U.S. Preventive Services Task Force (USPSTF) recently issued guidelines on screen

255 ed following the 2008 US Preventive Services Task Force (USPSTF) recommendation against prostate-spec

256 icantly following the US Preventive Services Task Force (USPSTF) recommendation against prostate-spec

257 To update the 2012 US Preventive Services Task Force (USPSTF) recommendation on behavioral counsel

258 To update the 2009 US Preventive Services Task Force (USPSTF) recommendation on folic acid supplem

259 e: To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on primary care inter

260 To update the 2011 US Preventive Services Task Force (USPSTF) recommendation on screening for ambl

261 To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for celi

262 Update of the 2009 US Preventive Services Task Force (USPSTF) recommendation on screening for depr

263 e: To update the 2005 US Preventive Services Task Force (USPSTF) recommendation on screening for geni

264 To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for gyne

265 Update of the US Preventive Services Task Force (USPSTF) recommendation on screening for impa

266 e: To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on screening for lipi

267 To update the 2010 US Preventive Services Task Force (USPSTF) recommendation on screening for obes

268 To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for OSA

269 To update the 1996 US Preventive Services Task Force (USPSTF) recommendation on screening for pree

270 To update the US Preventive Services Task Force (USPSTF) recommendation on screening for thyr

271 To update the 2012 US Preventive Services Task Force (USPSTF) recommendation on the use of menopau

272 Update of the 1996 U.S. Preventive Services Task Force (USPSTF) recommendation statement on counseli

273 Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screenin

274 Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screenin

275 Update of the 2003 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screenin

276 New U.S. Preventive Services Task Force (USPSTF) recommendation statement on screenin

277 New U.S. Preventive Services Task Force (USPSTF) recommendation statement on vitamin

278 f the 2003 and 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statements on behavio

279 2015, the United States Preventive Services Task Force (USPSTF) recommended targeted screening for p

280 The US Preventive Services Task Force (USPSTF) recommends computed tomography (CT)

281 A 2005 U.S. Preventive Services Task Force (USPSTF) review found good evidence that HIV

282 Preventive Services Task Force (USPSTF) summarizes the principles and consid

283 This year, the U.S. Preventive Services Task Force (USPSTF) will update its 2004 hepatitis C gui

284 ded by the United States Preventive Services Task Force (USPSTF), comparison of these to the Centers

285 ic conditions for the US Preventive Services Task Force (USPSTF).

286 ports of complication, a Microsurgery Safety Task Force was convened to evaluate the scientific evide

287 es, a multidisciplinary, multi-institutional task force was convened, incorporating expertise in crit

288 PROviding better Access To Organs (PROACTOR) Task Force was created to inform ongoing ASTS organ acce

289 The task force was divided into four subcommittees, focusing

290 The aim of this Task Force was the assessment of the quality of commerci

291 The aim of this EAACI task force was to review the essential points for monito

292 The task force was unable to reach agreement on a single tes

293 e context of this EAACI Lifestyle and asthma Task Force, we summarize the evidence from existing syst

294 Members of the task force were divided into 13 subcommittees, each focu

295 Several activities, coordinated by a task force, were implemented to assess and manage the ri

296 ive nominated members to the Choosing Wisely task force, which established explicit criteria for eval

297 ction of a Work Group chairperson, the Joint Task Force will discuss and resolve all relevant potenti

298 ection of a Workgroup chairperson, the Joint Task Force will discuss and resolve all relevant potenti

299 rson, multidisciplinary, multi-institutional task force with expertise in guideline development, pain

300 se tests is currently undergoing review by a task force within the American Thyroid Association.